To The Moon

I’d want to see positive free cash flow, sustainable margins, and real customer demand rather than just big AI spending promises. Long-term contracts and lower reliance on debt would also help rebuild confidence. Revenue growth is exciting, but profitability is what makes the model credible.

good analysis

What a difference a day makes. Earlier this week, memory looked almost uninvestable. CXMT's server DRAM expansion triggered fears that Chinese supply could weaken the scarcity economics behind the memory supercycle. MU, SNDK and SK Hynix were hammered. Then came 15 October. Buyers returned and memory stocks bounced. One green session does not make a bottom. But after such violent selling, I am asking a different question now: Has the market finally found a price where investors are willing to defend the memory thesis? I think we may be getting our first clue. 🔴 THE CXMT THREAT IS REAL, BUT THE MARKET JUMPED SEVERAL STEPS AHEAD The bearish argument effectively became: CXMT improves technology → production surges → DRAM supply rises → pricing collapses → Micron margins collapse. Possible? Ye

CXMT Targets Server Memory: Is the Memory Repricing Done? Here's What the Numbers Say, and Why I'm Not Selling Puts Yet Written Friday 16 Oct, SGT, after Thursday's US session. Last weekend in Shanghai, CXMT president Cao Kanyu said China's largest DRAM maker plans to launch a DDR5 RDIMM server module built on its new 4F² cell design by the end of 2026. A 4F² cell takes up roughly a third less area than the 6F² design the industry still uses, so you get more memory per chip. CXMT says it holds more than 300 patent families on the architecture. That's the headline. Here's what wasn't said: no speed, no capacity, no yield and no volume. It's a product launch target, not a commitment to mass production or to qualification at the big server platforms. The market didn't wait for the details. Fr

For me, the neocloud model becomes credible again when it proves cash returns, not just revenue growth and huge backlogs. I would look for high GPU utilisation, positive free cash flow after capex and interest, and contracts that remain profitable as GPUs age and rental prices fall. Customer diversification is also important because dependence on a few hyperscalers increases risk. The strongest evidence would be neoclouds funding more of their next GPU cycle from operating cash rather than repeatedly adding debt. My credibility test: utilisation → cash flow → lower leverage → diversified customers. If these improve while AI compute demand remains strong, the model deserves another look. If revenue rises but debt and capex grow even faster, the core concern remains unresolved.

I would focus on HBM rather than chase a broad memory rebound. SK Hynix still has the strongest technology and market position in HBM, while Micron may offer the more interesting catch-up story if it continues gaining HBM share and securing long-term AI orders. Micron has also said demand should exceed supply through 2027 and 2028, which suggests CXMT’s expansion may not immediately create an industry-wide glut. CXMT is a genuine longer-term threat, especially in conventional server DRAM, but advanced HBM remains much harder to replicate at scale. SanDisk and WDC could recover with strong data-centre storage demand, but that is a somewhat different AI infrastructure thesis and I would rank it behind HBM for now. My preference: SK Hynix technology lead > Micron HBM share gains > SanDi

I see this as a valuation reset rather than the end of the AI story. AI demand remains strong, but investors are becoming more selective about capital spending, financing costs and cash flow. Growth alone is no longer enough when valuations are stretched. Personally, I would consider healthcare and consumer staples for diversification, as their earnings tend to be more resilient. However, I would not chase defensive stocks simply because they are outperforming. Valuation and cash flow still matter, especially in a higher-for-longer interest rate environment. For my portfolio, I prefer to stay disciplined rather than react to short-term rotations. I will monitor Treasury yields, earnings and technical levels while continuing to accumulate quality companies patiently on pullbacks. Consisten

① Healthcare — stable demand and predictable earnings. I favor healthcare, not because AI has lost its future, but because investors are reassessing distant growth. Sticky inflation and higher Treasury yields pressure businesses requiring massive capital spending before generating cash flow. Healthcare companies benefit from resilient demand and relatively stable earnings. However, defensive stocks are not automatically bargains. Patent expirations, regulatory pressure and excessive valuations can still destroy returns. The market is repricing earnings certainty. AI may continue transforming the economy, but investors are becoming less willing to pay any price for growth. My strategy: favor fairly valued healthcare companies with durable cash flows. When uncertainty rises, investors should

Nice Sharing 😁 leaning more towards health care [Smile]. @Barcode @Shyon @koolgal @JC888 @DiAngel @Aqa @Shernice軒嬣 2000

$MU$   Micron Technology is stuck in a spiral amid concerns about Chinese competition and the artificial-intelligence trade in general. But shareholder returns could help it rebound, according to analysts. Micron shares were down 4.4% at $873.70 in premarket trading. A slide that began at the start of the week on news that China's CXMT was developing a new memory chip has been compounded by fears about the wider AI trade. South Korean memory companies Samsung Electronics and SK Hynix were even harder hit, dropping 9.5% and 11%, respectively, in local trading on Thursday. But the worries are overblown, according to UBS analyst Nicolas Gaudois. He notes that CXMT's so-called 4F square des

Recently, Genki Forest partnered with YXT.com Group Holding Limited ( $云学堂(YXT)$ ) to introduce AI-powered role-play training, transforming real business scenarios into interactive environments where employees can repeatedly practice, receive feedback, and improve. The collaboration explores a new approach to moving from experience transfer to scalable capability development. For fast-growing consumer companies, helping new employees quickly adapt to frontline business is critical not only for talent development efficiency, but also for preserving and replicating organizational experience. As part of its “Qingmiao Program,” Genki Forest faced the challenge of scaling up training for a growing number of new graduates. Traditional classroom sessions,

This memory correction has gone from uncomfortable to brutal. Micron has fallen from above $1,000 to roughly $874 in the screenshot. SanDisk is around $1,336. SK Hynix has been hammered, and leveraged memory products have suffered even more. The immediate culprit is China's CXMT. Its new 4F² DRAM architecture potentially allows more memory cells to fit into the same area, and CXMT says it intends to launch server-grade DDR5 products using the technology before year-end. That matters. But there is one enormous distinction investors should not overlook: CXMT has demonstrated technological progress. It has not yet demonstrated high-volume, high-yield, economically competitive production. The market is currently pricing those two things almost as if they were the same. I think that is prematur

U.S. stocks showed a striking divergence in the latest trading session. The Nasdaq fell 1.88%, while the Philadelphia Semiconductor Index dropped 4.3%, marking its sixth consecutive daily decline. Oracle plunged nearly 9%, CoreWeave lost around 15%, and several AI infrastructure names remained under heavy pressure. Meanwhile, healthcare and consumer staples moved in the opposite direction, gaining approximately 2.4% and 2.1%, respectively, during the session. Traditional defensive names such as Procter & Gamble and Johnson & Johnson attracted renewed interest. On the same day AI stocks were being sold aggressively, companies selling everyday essentials and healthcare products were finding buyers. The interesting question is not simply why technology stocks fell. It is why investors

The market: inflation returned as AI hardware faced both rate and earnings pressure The $S&P 500(.SPX)$ fell 1.11 per cent to 7,718.94 on Wednesday, while $Invesco QQQ(QQQ)$ lost 1.97 per cent to close at US$728.95. Headline CPI rose 3.7 per cent from a year earlier in September, above the market's 3.6 per cent expectation and August's 3.4 per cent reading. The return of inflation pushed rate expectations higher, and technology fell substantially more than the broader market. As rate expectations move higher, the present value of future earnings falls; the more a share price depends on growth further into the future, the greater the valuation pressure. AI hardware also f

Micron, SK Hynix, SanDisk and Western Digital have come under pressure as investors reassess the memory sector. But is CXMT about to disrupt the industry, or is the market getting ahead of itself? 🇨🇳 What triggered the sell-off? China’s memory-chip maker CXMT has reported progress on a denser DRAM design known as 4F², with plans to introduce a DDR5 server memory module by the end of 2026. The design aims to reduce the memory cell’s footprint compared with conventional 6F² designs. If CXMT can manufacture it efficiently and at scale, it could eventually increase competition in the server memory market. That matters because memory prices and supply constraints have helped drive strong earnings across the industry. But there is an important distinction: announcing a technology milestone is no

A new competitor can change an industry’s future without immediately changing its earnings. That distinction matters for memory stocks right now. $Micron Technology (MU)$, $SK Hynix$ and $SanDisk (SNDK)$ have come under pressure as China’s CXMT signals plans to enter the server DRAM market with a denser memory design. The sell-off reflects growing concerns about competition, pricing power and the sustainability of memory makers’ recent profits. But is the market looking too far ahead? 🔍 1. A technology announcement is not the same as mass production CXMT reportedly aims to introduce a DDR5 server memory product using a 4F² cell design by the end of 2026. The design could improve memory density, but several questions remain unanswered: • Can CXMT manufacture the chips reliably at commercial

[开心]  [开心]  [开心]  [开心]  

1

I think option ④ is the most reasonable for now. AI memory demand remains strong, and $Cxmt Corporation(688825)$ CXMT’s technological progress does not automatically mean it can achieve mass production at competitive costs or quickly challenge established players. I believe the memory supercycle is still intact for now, but today’s selloff reminds me that no growth story moves in a straight line. I will be watching DRAM pricing, production capacity and customer demand to see whether the supply-demand balance is genuinely changing. For $Micron Technology(MU)$ , I prefer to stay patient rather than panic over short-term volatility. Competition is worth monitoring, but I would not assume the memory upcycle

③ — Earnings remain strong, but the market may be pricing in a cycle reversal. The biggest risk to memory stocks isn't collapsing AI demand; it's assuming today's exceptional profits will last forever. CXMT's 4F² architecture could improve memory density and cost efficiency, but commercial yields, mass production and server qualification remain unproven. Meanwhile, TrendForce still forecasts Q4 conventional DRAM contract prices rising 10–15%, suggesting near-term supply remains tight. Here's the deeper issue: stocks move on future expectations, not just current earnings. When margins approach their peak, even record profits may fail to support valuations if investors anticipate tougher competition. I'd watch DRAM pricing, production yields and HBM competitiveness rather than panic over on

What a difference a day makes. Earlier this week, memory looked almost uninvestable. CXMT's server DRAM expansion triggered fears that Chinese supply could weaken the scarcity economics behind the memory supercycle. MU, SNDK and SK Hynix were hammered. Then came 15 October. Buyers returned and memory stocks bounced. One green session does not make a bottom. But after such violent selling, I am asking a different question now: Has the market finally found a price where investors are willing to defend the memory thesis? I think we may be getting our first clue. 🔴 THE CXMT THREAT IS REAL, BUT THE MARKET JUMPED SEVERAL STEPS AHEAD The bearish argument effectively became: CXMT improves technology → production surges → DRAM supply rises → pricing collapses → Micron margins collapse. Possible? Ye

CXMT Targets Server Memory: Is the Memory Repricing Done? Here's What the Numbers Say, and Why I'm Not Selling Puts Yet Written Friday 16 Oct, SGT, after Thursday's US session. Last weekend in Shanghai, CXMT president Cao Kanyu said China's largest DRAM maker plans to launch a DDR5 RDIMM server module built on its new 4F² cell design by the end of 2026. A 4F² cell takes up roughly a third less area than the 6F² design the industry still uses, so you get more memory per chip. CXMT says it holds more than 300 patent families on the architecture. That's the headline. Here's what wasn't said: no speed, no capacity, no yield and no volume. It's a product launch target, not a commitment to mass production or to qualification at the big server platforms. The market didn't wait for the details. Fr

This memory correction has gone from uncomfortable to brutal. Micron has fallen from above $1,000 to roughly $874 in the screenshot. SanDisk is around $1,336. SK Hynix has been hammered, and leveraged memory products have suffered even more. The immediate culprit is China's CXMT. Its new 4F² DRAM architecture potentially allows more memory cells to fit into the same area, and CXMT says it intends to launch server-grade DDR5 products using the technology before year-end. That matters. But there is one enormous distinction investors should not overlook: CXMT has demonstrated technological progress. It has not yet demonstrated high-volume, high-yield, economically competitive production. The market is currently pricing those two things almost as if they were the same. I think that is prematur

Recently, Genki Forest partnered with YXT.com Group Holding Limited ( $云学堂(YXT)$ ) to introduce AI-powered role-play training, transforming real business scenarios into interactive environments where employees can repeatedly practice, receive feedback, and improve. The collaboration explores a new approach to moving from experience transfer to scalable capability development. For fast-growing consumer companies, helping new employees quickly adapt to frontline business is critical not only for talent development efficiency, but also for preserving and replicating organizational experience. As part of its “Qingmiao Program,” Genki Forest faced the challenge of scaling up training for a growing number of new graduates. Traditional classroom sessions,

U.S. stocks showed a striking divergence in the latest trading session. The Nasdaq fell 1.88%, while the Philadelphia Semiconductor Index dropped 4.3%, marking its sixth consecutive daily decline. Oracle plunged nearly 9%, CoreWeave lost around 15%, and several AI infrastructure names remained under heavy pressure. Meanwhile, healthcare and consumer staples moved in the opposite direction, gaining approximately 2.4% and 2.1%, respectively, during the session. Traditional defensive names such as Procter & Gamble and Johnson & Johnson attracted renewed interest. On the same day AI stocks were being sold aggressively, companies selling everyday essentials and healthcare products were finding buyers. The interesting question is not simply why technology stocks fell. It is why investors

The market: inflation returned as AI hardware faced both rate and earnings pressure The $S&P 500(.SPX)$ fell 1.11 per cent to 7,718.94 on Wednesday, while $Invesco QQQ(QQQ)$ lost 1.97 per cent to close at US$728.95. Headline CPI rose 3.7 per cent from a year earlier in September, above the market's 3.6 per cent expectation and August's 3.4 per cent reading. The return of inflation pushed rate expectations higher, and technology fell substantially more than the broader market. As rate expectations move higher, the present value of future earnings falls; the more a share price depends on growth further into the future, the greater the valuation pressure. AI hardware also f

A new competitor can change an industry’s future without immediately changing its earnings. That distinction matters for memory stocks right now. $Micron Technology (MU)$, $SK Hynix$ and $SanDisk (SNDK)$ have come under pressure as China’s CXMT signals plans to enter the server DRAM market with a denser memory design. The sell-off reflects growing concerns about competition, pricing power and the sustainability of memory makers’ recent profits. But is the market looking too far ahead? 🔍 1. A technology announcement is not the same as mass production CXMT reportedly aims to introduce a DDR5 server memory product using a 4F² cell design by the end of 2026. The design could improve memory density, but several questions remain unanswered: • Can CXMT manufacture the chips reliably at commercial

I would focus on HBM rather than chase a broad memory rebound. SK Hynix still has the strongest technology and market position in HBM, while Micron may offer the more interesting catch-up story if it continues gaining HBM share and securing long-term AI orders. Micron has also said demand should exceed supply through 2027 and 2028, which suggests CXMT’s expansion may not immediately create an industry-wide glut. CXMT is a genuine longer-term threat, especially in conventional server DRAM, but advanced HBM remains much harder to replicate at scale. SanDisk and WDC could recover with strong data-centre storage demand, but that is a somewhat different AI infrastructure thesis and I would rank it behind HBM for now. My preference: SK Hynix technology lead > Micron HBM share gains > SanDi

I see this as a valuation reset rather than the end of the AI story. AI demand remains strong, but investors are becoming more selective about capital spending, financing costs and cash flow. Growth alone is no longer enough when valuations are stretched. Personally, I would consider healthcare and consumer staples for diversification, as their earnings tend to be more resilient. However, I would not chase defensive stocks simply because they are outperforming. Valuation and cash flow still matter, especially in a higher-for-longer interest rate environment. For my portfolio, I prefer to stay disciplined rather than react to short-term rotations. I will monitor Treasury yields, earnings and technical levels while continuing to accumulate quality companies patiently on pullbacks. Consisten

Micron, SK Hynix, SanDisk and Western Digital have come under pressure as investors reassess the memory sector. But is CXMT about to disrupt the industry, or is the market getting ahead of itself? 🇨🇳 What triggered the sell-off? China’s memory-chip maker CXMT has reported progress on a denser DRAM design known as 4F², with plans to introduce a DDR5 server memory module by the end of 2026. The design aims to reduce the memory cell’s footprint compared with conventional 6F² designs. If CXMT can manufacture it efficiently and at scale, it could eventually increase competition in the server memory market. That matters because memory prices and supply constraints have helped drive strong earnings across the industry. But there is an important distinction: announcing a technology milestone is no

$MU$   Micron Technology is stuck in a spiral amid concerns about Chinese competition and the artificial-intelligence trade in general. But shareholder returns could help it rebound, according to analysts. Micron shares were down 4.4% at $873.70 in premarket trading. A slide that began at the start of the week on news that China's CXMT was developing a new memory chip has been compounded by fears about the wider AI trade. South Korean memory companies Samsung Electronics and SK Hynix were even harder hit, dropping 9.5% and 11%, respectively, in local trading on Thursday. But the worries are overblown, according to UBS analyst Nicolas Gaudois. He notes that CXMT's so-called 4F square des

For me, the neocloud model becomes credible again when it proves cash returns, not just revenue growth and huge backlogs. I would look for high GPU utilisation, positive free cash flow after capex and interest, and contracts that remain profitable as GPUs age and rental prices fall. Customer diversification is also important because dependence on a few hyperscalers increases risk. The strongest evidence would be neoclouds funding more of their next GPU cycle from operating cash rather than repeatedly adding debt. My credibility test: utilisation → cash flow → lower leverage → diversified customers. If these improve while AI compute demand remains strong, the model deserves another look. If revenue rises but debt and capex grow even faster, the core concern remains unresolved.

Asian semiconductor stocks suffered a sharp selloff today. SK hynix dropped roughly 10%, Samsung Electronics fell 7.4%, South Korea’s KOSPI declined more than 5%, and Japan’s Kioxia also saw double-digit losses. What makes this interesting is that AI memory demand has not suddenly disappeared. Instead, investors are reacting to a potential shift in the global memory supply landscape, driven partly by a technological breakthrough from China. On October 12, Chinese memory manufacturer CXMT (ChangXin Memory Technologies) disclosed progress in its next-generation 4F² DRAM cell architecture, with plans to introduce server memory products using the technology by the end of this year. Compared with the industry’s mainstream 6F² structure, the new architecture could potentially increase memory den

I’d want to see positive free cash flow, sustainable margins, and real customer demand rather than just big AI spending promises. Long-term contracts and lower reliance on debt would also help rebuild confidence. Revenue growth is exciting, but profitability is what makes the model credible.

① Healthcare — stable demand and predictable earnings. I favor healthcare, not because AI has lost its future, but because investors are reassessing distant growth. Sticky inflation and higher Treasury yields pressure businesses requiring massive capital spending before generating cash flow. Healthcare companies benefit from resilient demand and relatively stable earnings. However, defensive stocks are not automatically bargains. Patent expirations, regulatory pressure and excessive valuations can still destroy returns. The market is repricing earnings certainty. AI may continue transforming the economy, but investors are becoming less willing to pay any price for growth. My strategy: favor fairly valued healthcare companies with durable cash flows. When uncertainty rises, investors should

Despite the $Roundhill Memory ETF(DRAM)$ Roundhill Memory ETF (DRAM) falling nearly 30% from its 2026 peak due to macroeconomic overvaluation fears and localized margin call liquidations, fundamental business conditions remain highly favorable. In this article, we would like to share a comprehensive structural analysis of the 2026 DRAM & NAND liquidation, rebound drivers, and risk factors. 1. Anatomy of the 2026 DRAM ETF Pullback The Roundhill Memory ETF (DRAM), launched in early 2026 to offer pure-play exposure to global memory manufacturers, recorded an extraordinary debut, surging over 110% as artificial intelligence infrastructure spending accelerated. However, during the mid-to-late quarters of 2026, the fund encountered severe selling pr

good analysis

Memory investors are getting nervous, and understandably so. Micron is now around $1,003, more than 18% below its recent high. SanDisk has fallen toward $1,548. SK Hynix remains under pressure, while leveraged memory trades have been hit much harder. After such a powerful run, an 18% drop can feel like the market is telling us something serious. Maybe it is. But I think we need to separate three very different things: A stock correction. A conventional DRAM downturn. A breakdown of the AI memory thesis. They are not the same. Right now, I see evidence of the first two concerns. I do not yet see enough evidence for the third. Why Has MU Fallen So Much? The uncomfortable answer is that the memory story became almost too successful. Investors spent months buying the same thesis: AI demand is

U.S. stock indexes keep pushing toward new highs, but the number of stocks actually making money for investors may be much smaller than you think. According to Reuters, citing LSEG data on October 12, the S&P 500 has gained roughly 14% year to date, yet more than 200 of its constituents are still trading lower, with about a quarter down 11% or more. Even more striking, the median return among S&P 500 stocks is only around 4%. In other words, the index looks like it is enjoying a strong bull market, but investors who missed a handful of major winners may have significantly underperformed. The more interesting question is not whether the market has risen too much, but why so much of the rally is concentrated in AI and semiconductor stocks. SanDisk and Micron have each surged more tha

Nice Sharing 😁 leaning more towards health care [Smile]. @Barcode @Shyon @koolgal @JC888 @DiAngel @Aqa @Shernice軒嬣 2000